| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 6 | 12.5 | 56 | 2,159.5 | 393.5 | - | - | - | 2,627.5 |
| - | - | - | 3 | 4.5 | 1,029.5 | 213 | - | - | - | 1,250 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 6 |
| 1 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 1 |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 5,249 | 97.2% | -1.07 | 2,500 | 98.3% |
| Optic-unspecified(L) | 136 | 2.5% | -1.70 | 42 | 1.7% |
| AME(L) | 12 | 0.2% | -2.58 | 2 | 0.1% |
| CentralBrain-unspecified | 1 | 0.0% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns Cm30 | % In | CV |
|---|---|---|---|---|---|
| MeTu1 (L) | 125 | ACh | 1,026.5 | 39.3% | 0.4 |
| Dm2 (L) | 293 | ACh | 332 | 12.7% | 0.8 |
| Cm12 (L) | 35 | GABA | 276.5 | 10.6% | 0.5 |
| Cm24 (L) | 6 | Glu | 139 | 5.3% | 0.6 |
| MeVC20 (L) | 2 | Glu | 137.5 | 5.3% | 0.2 |
| Mi15 (L) | 128 | ACh | 101.5 | 3.9% | 0.6 |
| MeVC8 (R) | 1 | ACh | 58.5 | 2.2% | 0.0 |
| MeTu3c (L) | 34 | ACh | 34.5 | 1.3% | 0.8 |
| MeTu3a (L) | 19 | ACh | 34 | 1.3% | 0.6 |
| aMe9 (L) | 2 | ACh | 30.5 | 1.2% | 0.0 |
| aMe17a (L) | 1 | unc | 28 | 1.1% | 0.0 |
| MeVC7b (R) | 1 | ACh | 22.5 | 0.9% | 0.0 |
| MeVP33 (L) | 1 | ACh | 20.5 | 0.8% | 0.0 |
| Cm8 (L) | 23 | GABA | 16 | 0.6% | 0.6 |
| Dm-DRA1 (L) | 14 | Glu | 15 | 0.6% | 0.6 |
| Cm21 (L) | 11 | GABA | 14.5 | 0.6% | 0.4 |
| Mi10 (L) | 22 | ACh | 14.5 | 0.6% | 0.5 |
| MeVC7a (R) | 1 | ACh | 12 | 0.5% | 0.0 |
| Cm22 (L) | 7 | GABA | 11 | 0.4% | 0.5 |
| Cm5 (L) | 16 | GABA | 11 | 0.4% | 0.4 |
| Cm3 (L) | 14 | GABA | 10 | 0.4% | 0.6 |
| Cm10 (L) | 6 | GABA | 9.5 | 0.4% | 1.5 |
| Cm14 (L) | 13 | GABA | 9.5 | 0.4% | 0.7 |
| MeVP7 (L) | 10 | ACh | 9.5 | 0.4% | 0.5 |
| Cm9 (L) | 11 | Glu | 9.5 | 0.4% | 0.7 |
| MeVP6 (L) | 14 | Glu | 9.5 | 0.4% | 0.6 |
| MeVPMe5 (R) | 5 | Glu | 9 | 0.3% | 1.2 |
| OLVC2 (R) | 1 | GABA | 9 | 0.3% | 0.0 |
| MeTu2a (L) | 11 | ACh | 9 | 0.3% | 0.5 |
| Cm23 (L) | 7 | Glu | 8 | 0.3% | 0.9 |
| Cm20 (L) | 7 | GABA | 8 | 0.3% | 0.4 |
| OA-AL2i4 (L) | 1 | OA | 7.5 | 0.3% | 0.0 |
| aMe10 (R) | 2 | ACh | 7.5 | 0.3% | 0.3 |
| MeVC6 (R) | 1 | ACh | 7 | 0.3% | 0.0 |
| MeVP42 (L) | 1 | ACh | 6.5 | 0.2% | 0.0 |
| Cm25 (L) | 3 | Glu | 6.5 | 0.2% | 0.3 |
| aMe17e (L) | 1 | Glu | 5.5 | 0.2% | 0.0 |
| ME_unclear (L) | 1 | Glu | 5 | 0.2% | 0.0 |
| MeVC27 (R) | 3 | unc | 5 | 0.2% | 0.6 |
| Cm16 (L) | 8 | Glu | 5 | 0.2% | 0.3 |
| LT58 (L) | 1 | Glu | 4.5 | 0.2% | 0.0 |
| Cm-DRA (L) | 3 | ACh | 4.5 | 0.2% | 0.3 |
| MeVC5 (R) | 1 | ACh | 4 | 0.2% | 0.0 |
| MeVP12 (L) | 3 | ACh | 4 | 0.2% | 0.6 |
| MeVP40 (L) | 1 | ACh | 4 | 0.2% | 0.0 |
| MeVPMe8 (L) | 2 | Glu | 4 | 0.2% | 0.2 |
| MeTu3b (L) | 7 | ACh | 4 | 0.2% | 0.3 |
| Cm30 (L) | 2 | GABA | 3.5 | 0.1% | 0.4 |
| aMe26 (L) | 3 | ACh | 3.5 | 0.1% | 0.4 |
| MeVP8 (L) | 6 | ACh | 3.5 | 0.1% | 0.3 |
| Dm20 (L) | 6 | Glu | 3.5 | 0.1% | 0.3 |
| MeVPMe9 (R) | 2 | Glu | 3 | 0.1% | 0.7 |
| MeVPLo2 (L) | 4 | ACh | 3 | 0.1% | 0.3 |
| MeLo3b (L) | 6 | ACh | 3 | 0.1% | 0.0 |
| Tm5c (L) | 6 | Glu | 3 | 0.1% | 0.0 |
| MeVC10 (R) | 1 | ACh | 2.5 | 0.1% | 0.0 |
| MeVC22 (L) | 1 | Glu | 2.5 | 0.1% | 0.0 |
| Cm35 (L) | 1 | GABA | 2.5 | 0.1% | 0.0 |
| Cm34 (L) | 1 | Glu | 2.5 | 0.1% | 0.0 |
| Cm4 (L) | 4 | Glu | 2.5 | 0.1% | 0.3 |
| Dm-DRA2 (L) | 3 | Glu | 2.5 | 0.1% | 0.3 |
| Cm31b (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| MeVC2 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeLo6 (L) | 2 | ACh | 2 | 0.1% | 0.5 |
| MeLo5 (L) | 2 | ACh | 2 | 0.1% | 0.5 |
| MeVP59 (L) | 2 | ACh | 2 | 0.1% | 0.5 |
| MeVP21 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Cm15 (L) | 3 | GABA | 2 | 0.1% | 0.4 |
| Cm28 (L) | 4 | Glu | 2 | 0.1% | 0.0 |
| Cm7 (L) | 2 | Glu | 1.5 | 0.1% | 0.3 |
| Pm12 (L) | 2 | GABA | 1.5 | 0.1% | 0.3 |
| MeVP43 (L) | 1 | ACh | 1.5 | 0.1% | 0.0 |
| Cm33 (L) | 1 | GABA | 1.5 | 0.1% | 0.0 |
| aMe5 (L) | 3 | ACh | 1.5 | 0.1% | 0.0 |
| Tm39 (L) | 3 | ACh | 1.5 | 0.1% | 0.0 |
| Cm11a (L) | 2 | ACh | 1.5 | 0.1% | 0.3 |
| TmY17 (L) | 3 | ACh | 1.5 | 0.1% | 0.0 |
| MeVPMe11 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVP46 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Mi1 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm34 (L) | 2 | Glu | 1 | 0.0% | 0.0 |
| Tm31 (L) | 2 | GABA | 1 | 0.0% | 0.0 |
| TmY10 (L) | 2 | ACh | 1 | 0.0% | 0.0 |
| MeVPaMe2 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Mi4 (L) | 2 | GABA | 1 | 0.0% | 0.0 |
| Cm6 (L) | 2 | GABA | 1 | 0.0% | 0.0 |
| MeLo4 (L) | 2 | ACh | 1 | 0.0% | 0.0 |
| Cm2 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP9 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVC21 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| aMe17b (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| Cm29 (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| MeVPMe7 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| 5-HTPMPV03 (R) | 1 | 5-HT | 0.5 | 0.0% | 0.0 |
| C3 (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| Tm5b (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP15 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP1 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeTu2b (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP45 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVPMe5 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| aMe12 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVPMe1 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPMe4 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPMe6 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPMe12 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| downstream partner | # | NT | conns Cm30 | % Out | CV |
|---|---|---|---|---|---|
| MeTu1 (L) | 125 | ACh | 1,558.5 | 40.5% | 0.4 |
| Dm2 (L) | 421 | ACh | 485 | 12.6% | 0.6 |
| Cm8 (L) | 87 | GABA | 200 | 5.2% | 0.7 |
| MeVPMe5 (L) | 9 | Glu | 167.5 | 4.4% | 0.5 |
| MeVPMe6 (L) | 1 | Glu | 144.5 | 3.8% | 0.0 |
| Cm6 (L) | 83 | GABA | 114.5 | 3.0% | 0.7 |
| MeVC20 (L) | 2 | Glu | 110 | 2.9% | 0.1 |
| MeVP9 (L) | 7 | ACh | 107.5 | 2.8% | 0.5 |
| MeVP56 (L) | 1 | Glu | 101.5 | 2.6% | 0.0 |
| Cm5 (L) | 67 | GABA | 99.5 | 2.6% | 0.7 |
| MeVP7 (L) | 11 | ACh | 98 | 2.5% | 0.5 |
| MeVP8 (L) | 7 | ACh | 55.5 | 1.4% | 0.4 |
| MeVP6 (L) | 40 | Glu | 47 | 1.2% | 0.7 |
| MeTu2a (L) | 24 | ACh | 44 | 1.1% | 0.6 |
| MeVPMe8 (L) | 2 | Glu | 33.5 | 0.9% | 0.7 |
| MeVP59 (L) | 2 | ACh | 30.5 | 0.8% | 0.4 |
| MeVP55 (L) | 2 | Glu | 27.5 | 0.7% | 0.3 |
| LT58 (L) | 1 | Glu | 27 | 0.7% | 0.0 |
| Cm12 (L) | 21 | GABA | 26 | 0.7% | 0.7 |
| MeVPMe3 (L) | 1 | Glu | 24 | 0.6% | 0.0 |
| MeTu3c (L) | 31 | ACh | 22.5 | 0.6% | 0.5 |
| MeTu2b (L) | 13 | ACh | 20.5 | 0.5% | 1.0 |
| Cm3 (L) | 27 | GABA | 20 | 0.5% | 0.6 |
| TmY10 (L) | 23 | ACh | 16.5 | 0.4% | 0.5 |
| MeVP54 (L) | 2 | Glu | 15.5 | 0.4% | 0.3 |
| Cm4 (L) | 21 | Glu | 15.5 | 0.4% | 0.5 |
| Mi16 (L) | 9 | GABA | 14.5 | 0.4% | 0.8 |
| Cm20 (L) | 7 | GABA | 13.5 | 0.4% | 1.2 |
| Cm-DRA (L) | 4 | ACh | 12.5 | 0.3% | 0.9 |
| MeVP29 (L) | 1 | ACh | 9 | 0.2% | 0.0 |
| MeTu4a (L) | 11 | ACh | 8 | 0.2% | 0.5 |
| MeVPMe11 (L) | 1 | Glu | 7.5 | 0.2% | 0.0 |
| MeVP21 (L) | 3 | ACh | 7 | 0.2% | 0.5 |
| Cm23 (L) | 5 | Glu | 7 | 0.2% | 0.7 |
| Tm37 (L) | 10 | Glu | 6 | 0.2% | 0.3 |
| Cm31b (L) | 1 | GABA | 5.5 | 0.1% | 0.0 |
| MeVP14 (L) | 7 | ACh | 5.5 | 0.1% | 0.6 |
| Cm9 (L) | 9 | Glu | 5 | 0.1% | 0.3 |
| MeVPaMe2 (L) | 1 | Glu | 4.5 | 0.1% | 0.0 |
| MeVP40 (L) | 1 | ACh | 4.5 | 0.1% | 0.0 |
| Cm7 (L) | 2 | Glu | 4.5 | 0.1% | 0.1 |
| MeLo3a (L) | 6 | ACh | 4.5 | 0.1% | 0.7 |
| Dm-DRA1 (L) | 6 | Glu | 4.5 | 0.1% | 0.5 |
| TmY18 (L) | 8 | ACh | 4.5 | 0.1% | 0.3 |
| Cm30 (L) | 2 | GABA | 3.5 | 0.1% | 0.4 |
| MeVP12 (L) | 1 | ACh | 3.5 | 0.1% | 0.0 |
| Cm21 (L) | 4 | GABA | 3.5 | 0.1% | 0.5 |
| aMe9 (L) | 2 | ACh | 3.5 | 0.1% | 0.1 |
| Mi15 (L) | 6 | ACh | 3.5 | 0.1% | 0.3 |
| Mi17 (L) | 6 | GABA | 3.5 | 0.1% | 0.3 |
| Cm11c (L) | 5 | ACh | 3.5 | 0.1% | 0.3 |
| Cm25 (L) | 3 | Glu | 3 | 0.1% | 0.4 |
| Cm10 (L) | 6 | GABA | 3 | 0.1% | 0.0 |
| Cm28 (L) | 2 | Glu | 2.5 | 0.1% | 0.6 |
| l-LNv (L) | 3 | unc | 2.5 | 0.1% | 0.3 |
| MeTu4c (L) | 5 | ACh | 2.5 | 0.1% | 0.0 |
| MeVP1 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| aMe30 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| MeTu4f (L) | 2 | ACh | 2 | 0.1% | 0.5 |
| MeVPaMe1 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| Cm11a (L) | 3 | ACh | 2 | 0.1% | 0.4 |
| MeVP33 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| Cm33 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| MeVP15 (L) | 3 | ACh | 2 | 0.1% | 0.4 |
| Cm15 (L) | 3 | GABA | 2 | 0.1% | 0.4 |
| aMe5 (L) | 4 | ACh | 2 | 0.1% | 0.0 |
| Tm39 (L) | 4 | ACh | 2 | 0.1% | 0.0 |
| Cm14 (L) | 4 | GABA | 2 | 0.1% | 0.0 |
| MeLo6 (L) | 4 | ACh | 2 | 0.1% | 0.0 |
| aMe26 (L) | 2 | ACh | 1.5 | 0.0% | 0.3 |
| Cm16 (L) | 2 | Glu | 1.5 | 0.0% | 0.3 |
| Tm5c (L) | 1 | Glu | 1.5 | 0.0% | 0.0 |
| Tm33 (L) | 3 | ACh | 1.5 | 0.0% | 0.0 |
| MeTu3a (L) | 3 | ACh | 1.5 | 0.0% | 0.0 |
| Mi1 (L) | 3 | ACh | 1.5 | 0.0% | 0.0 |
| MeLo3b (L) | 3 | ACh | 1.5 | 0.0% | 0.0 |
| Cm11d (L) | 3 | ACh | 1.5 | 0.0% | 0.0 |
| MeVPMe9 (L) | 3 | Glu | 1.5 | 0.0% | 0.0 |
| Tm_unclear (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm29 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeVP45 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVC22 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| OA-AL2i4 (L) | 1 | OA | 1 | 0.0% | 0.0 |
| aMe17e (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Tm16 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm9 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVPMe4 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| ME_unclear (L) | 2 | Glu | 1 | 0.0% | 0.0 |
| MeVPMe5 (R) | 2 | Glu | 1 | 0.0% | 0.0 |
| MeVP42 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Mi2 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Li37 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Cm24 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeLo5 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm2 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Mi9 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| aMe_unclear (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeTu4d (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Tm20 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| TmY9a (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Tm34 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPLo2 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVC10 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| DN1a (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVP43 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| aMe25 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Cm31a (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| Tm12 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| TmY5a (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Mi10 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Lat3 (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| MeVP2 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm1 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| TmY4 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| TmY20 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Tm24 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm13 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Tm30 (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| TmY21 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Pm2a (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| MeTu3b (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVP32 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| aMe12 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm34 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPMe7 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| LT88 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Cm35 (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| MeVC27 (R) | 1 | unc | 0.5 | 0.0% | 0.0 |
| aMe17a (L) | 1 | unc | 0.5 | 0.0% | 0.0 |